Samuel Lagercrantz: Se upp också med de fina tidskrifterna

Kvalitet och anseende går inte alltid hand i hand. Samuel Lagercrantz skriver om högstatustidskrifter och hype i journalistik och vetenskap.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Blodtest hittar tidig alzheimer

Test som utvecklats av forskare vid Göteborgs universitet detekterar alzheimer med ett enkelt blodprov.

Nya datum för spännande event

The Future of Swedish & Danish Life Science och New Updates in Drug Formulation & Bioavailability flyttas fram till september.

Pilots want to live too

Krönika: Collaboration across borders

Drug development creates new challenges for regulators

Scilifelab-spinoff får ny vd

Mårten Winge tar över rollen som vd på Cartana.

”Nu är vi ett fas III-bolag som är på god väg att nå marknaden”

Ascelias kontrastmedel med orphan drug-status prövas i fas III – hoppas nå marknaden år 2022.

Swedish and Danish Life Science – are there still untapped synergies?

With the increasing developments in life sciences over the past decade and strong support for the sector’s strategic importance from both the Sweden and Danish governments, the timing of The Future of Swedish & Danish Life Science conference could

Cline får SME-status

”Syftet med EMA-certifieringen är att enklare och smidigare kunna påbörja kliniska studier och öka chanserna att ta rätt beslut redan från början”

Upcoming event: New updates on drugs

At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.

Framtidens laboratorium i fokus på fackmässan Analytica

Messe München laddar för att återigen ta emot världens laboratoriebransch

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and research could become a reality. Kajsa M Paulsson is the project leader for HALOS, driving the idea forward.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life science village is home to over 150 organisations, employing more than 2,200 people.

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.

Single Technologies tar in 15 miljoner

Single Technologies, utvecklare av instrument och mjukvara för genomik inom life science har avslutat en övertecknad emission på 15 miljoner kronor.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards an exit early 2020.

Farligast med hjärtinfarkt i Norrbotten

Stor skillnad i risken att dö mellan länen – Skillnaden ökar.

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

"Att välja en CMO är som att ingå ett äktenskap"

Välj partner omsorgsfullt och ta kontakt tidigt var två slutsatser från mötet Pharma Outsourcing.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of Development at Spago Nanomedical says.

Substans i magisk svamp får genombrottsstatus

Den aktiva substansen i magic mushrooms får breakthrough-status hos FDA som behandling mot depression.